Impact of pre-analytic step duration on molecular diagnosis of toxoplasmosis for five types of biological samples

PLoS One. 2021 Feb 17;16(2):e0246802. doi: 10.1371/journal.pone.0246802. eCollection 2021.

Abstract

Introduction: Toxoplasma-PCR is essential to diagnose ocular, cerebral, disseminated and congenital toxoplasmosis. This multicenter study evaluated the impact of sample storage duration at +4°C on PCR assay performances in order to propose guidelines for the storage of samples during shipment or/and before PCR.

Materials and methods: Five matrices, amniotic (AF), cerebrospinal (CSF), and bronchoalveolar lavage fluids (BALF), whole blood (WB) and buffy coat (BC), were artificially spiked with different amounts of Toxoplasma gondii (20, 100, 500 tachyzoites per mL of sample) or with previously infected THP1 cells. DNA extractions were performed at day 0 and after 2, 4 and 7 days of storage at +4°C. Each extract was amplified at least twice by real-time PCR.

Results: A total of 252 spiked samples was studied. No increase of crossing point was observed and all samples were positive for AF, BALF, BC and infected THP1-spiked WB after up to 7 days at 4°C. For CSF spiked with 20 parasites/mL, only 50% of PCR reactions were positive at D7 (p<0.05). For WB spiked with type II parasites, all reactions remained positive at D7 but amplifications were significantly delayed from D2; and for WB spiked with RH strain, the proportion of positive reactions decreased at D7.

Conclusion: The storage of clinical samples at +4°C is compatible with the molecular detection of T. gondii parasites. Provided that PCR assays are performed in duplicate, storage of samples is possible up to 7 days. However, from the fifth day onwards, and for samples susceptible to contain low parasitic loads, we recommend to perform the PCR in multiplicate.

Publication types

  • Evaluation Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA, Protozoan* / chemistry
  • DNA, Protozoan* / genetics
  • DNA, Protozoan* / isolation & purification
  • Female
  • Humans
  • Male
  • Preservation, Biological*
  • Real-Time Polymerase Chain Reaction*
  • Specimen Handling*
  • Time Factors
  • Toxoplasma / genetics*
  • Toxoplasmosis, Congenital* / diagnosis
  • Toxoplasmosis, Congenital* / genetics

Substances

  • DNA, Protozoan

Grants and funding

This work was supported by the French Ministry of Health through Santé Publique France to the Molecular Biology group of the French National Reference Centre for Toxoplasmosis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.